
Resources|Articles|November 8, 2024
The rewards of planning ahead: designing for full GMP production at pilot scale
Author(s)Avantor
Can biopharma manufacturers avoid extra costs, potential problems and wasted production time by designing a fully compliant (cGMP) manufacturing process early on? This article explores where planning ahead, using compendial raw materials of the highest quality and purity, can yield substantial benefits to both productivity and patient safety.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5